两家公司表示,在合作的初始阶段,Ares开发了一个数字抗感染平台,将微生物学实验室实践与先进的生物信息学和人工智能方法相结合,以帮助识别有效的抗菌化合物...查看全文
蹊之美股生物医药2021-10-08 00:15
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Voyager Therapeutics (NASDAQ:VYGR) +56%
Acer Therapeutics (NASDAQ:ACER) +16%
Molecular Partners (NASDAQ:MOLN) +10%
Rafael (NYSE:RFL) +6%
Arcturus Therapeutics (NASDA...查看全文
东哥_Singapore2021-03-08 23:42
$Jaguar Health(JAGX)$ 给力点啊,速度冲2.5!刚才在2.9的OPGN跟1.85的你之间,最后选的你!不要让我失望啊!OPGN已经爆拉了!!!$OpGen(OPGN)$查看全文
$OpGen(OPGN)$ 内部交易: 2020-04-23,10% Owner,Curetis N.V. in Liquidation ,卖出,46612普通股, $2.17
$OpGen(OPGN)$ 内部交易: 2020-04-22,10% Owner,Curetis N.V. in Liquidation ,卖出,42375普通股, $2.24
$OpGen(OPGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-20-009641 Size: 7 KB 网页链接
$OpGen(OPGN)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001140361-20-009399 Act: 34 Size: 55 KB 网页链接
$OpGen(OPGN)$ 内部交易: 2020-04-21,10% Owner,Curetis N.V. in Liquidation ,卖出,95609普通股, $2.30
$OpGen(OPGN)$ 内部交易: 2020-04-20,10% Owner,Curetis N.V. in Liquidation ,卖出,55142普通股, $2.35
$OpGen(OPGN)$ 内部交易: 2020-04-17,10% Owner,Curetis N.V. in Liquidation ,卖出,165902普通股, $2.46
$OpGen(OPGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-20-009398 Size: 9 KB 网页链接
$OpGen(OPGN)$ 8-K Current report, item 8.01 Accession Number: 0001079973-20-000296 Act: 34 Size: 20 KB 网页链接
$OpGen(OPGN)$ AW Amendment Withdrawal Request Accession Number: 0001079973-20-000299 Act: NE Size: 7 KB 网页链接